We are live on ! Find out more
RGNX icon

Regenxbio
RGNX

183 hedge funds and large institutions have $927M invested in Regenxbio in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 65 increasing their positions, 59 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

158% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 12

23% more call options, than puts

Call options by funds: $2.8M | Put options by funds: $2.27M

11% more funds holding

Funds holding: 165 → 183 (+18)

10% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 59

4% more capital invested

Capital invested by funds: $894M → $927M (+$32.6M)

2.78% less ownership

Funds ownership: 83.9% → 81.12% (-2.8%)

Holders
183
Holders Change
+18
Holders Change %
+10.91%
% of All Funds
3.15%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
31
Increased
65
Reduced
59
Closed
12
Calls
$2.8M
Puts
$2.27M
Net Calls
+$523K
Net Calls Change
-$385K

Top Buyers

1
MB
MPM BioImpact
Massachusetts
+$18.4M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$5.24M
3
Goldman Sachs
Goldman Sachs
New York
+$3.89M
4
MPAM
Monarch Partners Asset Management
Massachusetts
+$2.95M
5
Bank of America
Bank of America
North Carolina
+$2.8M

Top Sellers

1
SI
Sofinnova Investments
California
-$16.7M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$16.3M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$8.97M
4
RCMNY
Rubric Capital Management (New York)
New York
-$7.1M
5
ACM
Aquilo Capital Management
California
-$5.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$173M -$2.28M -76,847 -1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$113M +$452K +15,219 +0.4%
JP Morgan Chase
3
JP Morgan Chase
New York
$107M -$5.64M -190,241 -4%
State Street
4
State Street
Massachusetts
$69.2M -$5.38M -181,390 -6%
RG
5
Redmile Group
California
$50.7M -$2.59M -87,451 -4%
RI
6
RTW Investments
New York
$48.8M – – –
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$33.1M +$5.24M +176,607 +16%
ACM
8
Aquilo Capital Management
California
$25.6M -$5.93M -200,000 -17%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$18.7M +$232K +7,805 +1%
First Manhattan
10
First Manhattan
New York
$18.7M – – –
Goldman Sachs
11
Goldman Sachs
New York
$16.7M +$3.89M +131,038 +26%
MB
12
MPM BioImpact
Massachusetts
$16.4M +$18.4M +619,083 New
Northern Trust
13
Northern Trust
Illinois
$12.9M +$1.93M +65,060 +15%
Invesco
14
Invesco
Georgia
$11.1M -$2.95M -99,514 -19%
WM
15
WS Management
Florida
$10.5M -$593K -20,000 -5%
Morgan Stanley
16
Morgan Stanley
New York
$9.2M -$4.71M -158,675 -31%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$8.99M +$139K +4,695 +1%
Norges Bank
18
Norges Bank
Norway
$8.63M – – –
American Century Companies
19
American Century Companies
Missouri
$8.32M +$2.23M +75,053 +31%
Charles Schwab
20
Charles Schwab
California
$7.37M +$131K +4,431 +2%
AI
21
ArchPoint Investors
Florida
$6.68M -$16.4K -553 -0.2%
Principal Financial Group
22
Principal Financial Group
Iowa
$6.45M -$442K -14,902 -6%
Ameriprise
23
Ameriprise
Minnesota
$5.96M -$234K -7,885 -3%
T. Rowe Price Associates
24
T. Rowe Price Associates
Maryland
$5.84M +$34K +1,146 +0.5%
SI
25
Sofinnova Investments
California
$5.66M -$16.7M -562,665 -72%
1
2 3 4 5

RGNX Hedge Fund Activity: Q3 2022 in Review

183 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q3 2022, worth a combined $927M — up 3.6% from $894M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new RGNX positions and 12 closed out — a net gain of 19 holders — while 65 added to existing stakes and 59 trimmed.

The largest buyer was MPM BioImpact, opening a new position worth an estimated $18.4M. The largest seller was Sofinnova Investments, cutting an estimated $16.7M.

  • 183 institutional investors held Regenxbio (RGNX) as of Q3 2022, up from 165 in Q2 2022.
  • Funds reported $927M of Regenxbio stock for Q3 2022, up 3.6% quarter-over-quarter.
  • 31 funds opened new Regenxbio positions in Q3 2022 and 12 closed out, a net change of +19 holders.
  • The largest Regenxbio buyer in Q3 2022 was MPM BioImpact, an estimated $18.4M added.
  • The largest Regenxbio seller in Q3 2022 was Sofinnova Investments, an estimated $16.7M sold.

Based on aggregated 13F filings for Q3 2022.